Canada markets open in 3 hours 17 minutes

Raphael Pharmaceutical Inc. (RAPH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
At close: 10:30AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
834
569
1,178
776
461
Selling General and Administrative
727
703
2,139
853
245
Total Operating Expenses
1,561
1,272
3,317
1,629
706
Operating Income or Loss
-1,561
-1,272
-3,317
-1,629
-706
Total Other Income/Expenses Net
-
-9
-38
-
-
Income Before Tax
-1,570
-1,284
-3,358
-1,624
-718
Income from Continuing Operations
-1,570
-1,284
-3,358
-1,624
-718
Net Income
-1,570
-1,284
-3,358
-1,624
-718
Net Income available to common shareholders
-1,570
-1,284
-3,358
-1,624
-718
Basic EPS
-0.17
-
-0.23
-0.10
-0.05
Diluted EPS
-0.17
-
-0.23
-0.10
-0.05
Basic Average Shares
15,378
-
14,342
15,484
15,484
Diluted Average Shares
18,102
-
14,342
15,484
15,484